ELEVANCE HEALTH, INC. Operating Lease Cost
ELEVANCE HEALTH, INC. (ELV) reported Operating Lease Cost of $116.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-06
- ELEVANCE HEALTH, INC. operating lease, cost for the quarter ending 2023-12-31 was $29.00M, a 32.56% decline year-over-year.
- ELEVANCE HEALTH, INC. operating lease, cost for the quarter ending 2023-09-30 was $69.00M, a 97.14% increase year-over-year.
- ELEVANCE HEALTH, INC. operating lease, cost for the quarter ending 2023-06-30 was $32.00M, a 3.03% decline year-over-year.
- ELEVANCE HEALTH, INC. operating lease, cost for the quarter ending 2023-03-31 was $25.00M, a 10.71% decline year-over-year.
- ELEVANCE HEALTH, INC. operating lease, cost for fiscal 2025 was $116.00M, a 21.09% decline from fiscal 2024.
- ELEVANCE HEALTH, INC. operating lease, cost for fiscal 2024 was $147.00M, a 5.16% decline from fiscal 2023.
- ELEVANCE HEALTH, INC. operating lease, cost for fiscal 2023 was $155.00M, a 8.39% increase from fiscal 2022.
- ELEVANCE HEALTH, INC. operating lease, cost for fiscal 2022 was $143.00M, a 45.21% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $116.00M 10-K · filed 2026-02-06 | |||
| 2024-12-31 | $147.00M 10-K · filed 2026-02-06 | |||
| 2023-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $98.00M derived: sum of 2 quarters · filed 2026-02-06 | $130.00M derived: sum of 3 quarters · filed 2026-02-06 | $155.00M 10-K · filed 2026-02-06 |
| 2023-09-30 | $69.00M 10-Q · filed 2023-10-18 | $101.00M derived: sum of 2 quarters · filed 2023-10-18 | $126.00M 10-Q · filed 2023-10-18 | $169.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $32.00M 10-Q/A · filed 2023-09-29 | $57.00M 10-Q/A · filed 2023-09-29 | $100.00M derived: sum of 3 quarters · filed 2025-02-20 | $135.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $25.00M 10-Q · filed 2023-04-19 | $68.00M derived: sum of 2 quarters · filed 2025-02-20 | $103.00M derived: sum of 3 quarters · filed 2025-02-20 | $136.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $78.00M derived: sum of 2 quarters · filed 2025-02-20 | $111.00M derived: sum of 3 quarters · filed 2025-02-20 | $143.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $35.00M 10-Q · filed 2023-10-18 | $68.00M derived: sum of 2 quarters · filed 2023-10-18 | $100.00M 10-Q · filed 2023-10-18 | $257.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $33.00M 10-Q/A · filed 2023-09-29 | $65.00M 10-Q/A · filed 2023-09-29 | $222.00M derived: sum of 3 quarters · filed 2024-02-21 | $259.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $28.00M 10-Q · filed 2023-04-19 | $189.00M derived: sum of 2 quarters · filed 2024-02-21 | $226.00M derived: sum of 3 quarters · filed 2024-02-21 | $260.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $161.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $198.00M derived: sum of 2 quarters · filed 2024-02-21 | $232.00M derived: sum of 3 quarters · filed 2024-02-21 | $261.00M 10-K · filed 2024-02-21 |
| 2021-09-30 | $37.00M 10-Q · filed 2022-10-19 | $71.00M derived: sum of 2 quarters · filed 2022-10-19 | $100.00M 10-Q · filed 2022-10-19 | $160.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-06-30 | $34.00M 10-Q · filed 2022-07-20 | $63.00M 10-Q · filed 2022-07-20 | $123.00M derived: sum of 3 quarters · filed 2023-10-18 | $395.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-03-31 | $29.00M 10-Q · filed 2022-04-20 | $89.00M derived: sum of 2 quarters · filed 2023-10-18 | $361.00M derived: sum of 3 quarters · filed 2023-10-18 | $420.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2020-12-31 | $60.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-10-18 | $332.00M derived: sum of 2 quarters · filed 2023-10-18 | $391.00M derived: sum of 3 quarters · filed 2023-10-18 | $438.00M 10-Q · filed 2023-10-18 |
| 2020-09-30 | $272.00M 10-Q · filed 2021-10-20 | $331.00M derived: sum of 2 quarters · filed 2021-10-20 | $378.00M 10-Q · filed 2021-10-20 | $438.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $59.00M 10-Q · filed 2021-07-21 | $106.00M 10-Q · filed 2021-07-21 | $166.00M derived: sum of 3 quarters · filed 2022-02-16 | $214.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $47.00M 10-Q · filed 2021-04-21 | $107.00M derived: sum of 2 quarters · filed 2022-02-16 | $155.00M derived: sum of 3 quarters · filed 2022-02-16 | $200.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $108.00M derived: sum of 2 quarters · filed 2022-02-16 | $153.00M derived: sum of 3 quarters · filed 2022-02-16 | $198.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $48.00M 10-Q · filed 2020-10-28 | $93.00M derived: sum of 2 quarters · filed 2020-10-28 | $138.00M 10-Q · filed 2020-10-28 | |
| 2019-06-30 | $45.00M 10-Q · filed 2020-07-29 | $90.00M 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $45.00M 10-Q · filed 2020-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |